- Home
- WLGS vs CLGN Comparison
WLGS vs CLGN Comparison
Compare WLGS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- CLGN
- Stock Information
- Founded
- WLGS 1981
- CLGN 2004
- Country
- WLGS Hong Kong
- CLGN Israel
- Employees
- WLGS N/A
- CLGN N/A
- Industry
- WLGS Engineering & Construction
- CLGN Industrial Specialties
- Sector
- WLGS Consumer Discretionary
- CLGN Health Care
- Exchange
- WLGS Nasdaq
- CLGN Nasdaq
- Market Cap
- WLGS 50.7M
- CLGN 44.1M
- IPO Year
- WLGS 2023
- CLGN N/A
- Fundamental
- Price
- WLGS $4.17
- CLGN $4.29
- Analyst Decision
- WLGS
- CLGN Strong Buy
- Analyst Count
- WLGS 0
- CLGN 2
- Target Price
- WLGS N/A
- CLGN $12.50
- AVG Volume (30 Days)
- WLGS 107.1K
- CLGN 17.8K
- Earning Date
- WLGS 11-26-2024
- CLGN 11-27-2024
- Dividend Yield
- WLGS N/A
- CLGN N/A
- EPS Growth
- WLGS N/A
- CLGN N/A
- EPS
- WLGS N/A
- CLGN N/A
- Revenue
- WLGS $6,825,879.00
- CLGN $689,000.00
- Revenue This Year
- WLGS N/A
- CLGN N/A
- Revenue Next Year
- WLGS N/A
- CLGN $670.03
- P/E Ratio
- WLGS N/A
- CLGN N/A
- Revenue Growth
- WLGS 63.69
- CLGN N/A
- 52 Week Low
- WLGS $0.40
- CLGN $3.61
- 52 Week High
- WLGS $5.00
- CLGN $6.99
- Technical
- Relative Strength Index (RSI)
- WLGS 60.36
- CLGN 54.40
- Support Level
- WLGS $3.15
- CLGN $3.61
- Resistance Level
- WLGS $5.00
- CLGN $4.58
- Average True Range (ATR)
- WLGS 0.65
- CLGN 0.23
- MACD
- WLGS 0.09
- CLGN 0.09
- Stochastic Oscillator
- WLGS 61.43
- CLGN 69.59
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.